Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo

This publication has 31 references indexed in Scilit:

• Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus Macaques
  Journal of Virology, 2013
• Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects
  The Journal of Infectious Diseases, 2012
• Whither monkeypox vaccination
  Vaccine, 2011
• A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
  Vaccine, 2010
• DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
  Virology, 2007
• Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
  Virology, 2007
• Immunity and immunological memory following smallpox vaccination
  Immunological Reviews, 2006
• Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
  Vaccine, 2006
• Characterization of Acute-Phase Humoral Immunity to Monkeypox: Use of Immunoglobulin M Enzyme-Linked Immunosorbent Assay for Detection of Monkeypox Infection during the 2003 North American Outbreak
  Clinical and Vaccine Immunology, 2005
• The Transmission Potential of Monkeypox Virus in Human Populations
  International Journal of Epidemiology, 1988